Showing results (1-10 of 829) with videos related to
Sort By:
Pageof 83
Endocrine Regulations|June 30, 2020
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitusDouglas Edward Barre, Kazimiera Amelia Mizier-BarreEndocrine Regulations|September 15, 2021
Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetesDouglas Edward Barre, Kazimiera Amelia Mizier-BarreCurrent Diabetes Reviews|September 15, 2018
Lignans' Potential in Pre and Post-onset Type 2 Diabetes ManagementDouglas Edward Barre, Kazimiera Amella Mizier-BarreRevue D'Elevage Et De Medecine Veterinaire Des Pays Tropicaux|January 1, 1981
[Seasonal cycle of strongylus in cattle on Réunion Island]N BarreChemistry and Physics of Lipids|March 15, 2003
A more detailed fatty acid composition of human lipoprotein(a)--a comparison with low density lipoproteinEdward BarreFrontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Human lipoprotein (a)-induced reduction of platelet aggregation is not mediated by apolipoprotein A's lysine-binding regionsDouglas BarreEndocrine Regulations|November 21, 2024
Various apolipoprotein E genotypes relate to responsiveness to flaxseed lignan complex in older persons with type 2 diabetes mellitusDouglas E Barre, Kazimiera A Mizier-Barre, Odette GrisctiEndocrine Regulations|September 17, 2025
Thus far there are no statistically significant differences between various apolipoprotein E genotypes in the cluster of seven responsiveness to a flaxseed oil supplement in persons with type 2 diabetesDouglas E Barre, Kazimiera A Mizier-Barre, Odette GrisctiLa Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|April 1, 1978
[Non-addictive properties of tiapride (1347)]J L BarrePageof 83